PB 78 of 2012
National Health (IVF/GIFT Program) Special Arrangement Amendment Instrument 2012 (No.2)
National Health Act 1953
I, KIM BESSELL, First Assistant Secretary A/g, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health, make this Instrument under subsections 100(1) and 100(2) of the National Health Act 1953.
Dated 25 September 2012
 
 
 
 
 
 
 
 
 
KIM BESSELL
First Assistant Secretary A/g
Pharmaceutical Benefits Divison
Department of Health and Ageing
1          Name of Instrument
            (1)        This Instrument is the National Health (IVF/GIFT Program)
                        Special Arrangement Amendment Instrument 2012 (No.2).
            (2)        This Instrument may also be cited as PB 78 of 2012.
2          Commencement
This Instrument commences on 1 October 2012.
3          Amendment of PB 93 of 2011
(1)                    Schedule 1 of the National Health (IVF/GIFT Program) Special Arrangement 2011 (PB 93 of 2011) is omitted and replaced by Schedule 1 of this Instrument.
            (2)        Schedule 2 makes other amendments to PB 93 of 2011.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Schedule 1        Pharmaceutical benefits covered by this Special Arrangement and related information
(sections 5,6 and 7)
 
 
Listed Drug
Form
Manner of Administration
Brand
Responsible Person
Section 100 only

Cetrorelix
Powder for injection 250 micrograms (as acetate) with diluent
Injection
Cetrotide
SG
D(100)

Choriogonadotropin Alfa
Solution for injection 250 micrograms in 0.5ml pre-filled pen
Injection
Ovidrel
SG
D(100)

Choriogonadotropin Alfa
Solution for injection 250 micrograms in 0.5 mL pre‑filled syringe
Injection
Ovidrel 
SG
D(100)

Chorionic Gonadotrophin
Injection set containing 3 ampoules powder for injection 1,500 units and 3 ampoules solvent 1 mL
Injection
Pregnyl
MK
 

Chorionic Gonadotrophin
Powder for injection 5’000 units with solvent
Injection
Pregnyl
MK
PB(100)

Corifollitropin Alfa
Solution for injection 100 micrograms in 0.5ml single dose pre‑filled syringes
Injection
Elonva
MK
 

Corifollitropin Alfa
Solution for injection 150 micrograms in 0.5ml single dose pre‑filled syringes
Injection
Elonva
MK
 

Follitropin Alfa
Injection 300 I.U. in 0.5 mL multi‑dose cartridge
Injection
Gonal‑f Pen
SG
 

Follitropin Alfa
Injection 450 I.U. in 0.75 mL multi‑dose cartridge
Injection
Gonal‑f Pen
SG
 

Follitropin Alfa
Injection 900 I.U. in 1.5 mL multi‑dose cartridge
Injection
Gonal‑f Pen
SG
 

Follitropin Beta
Solution for injection 300 I.U. in 0.36 mL multi‑dose cartridge
Injection
Puregon 300 IU/0.36 mL
MK
 

Follitropin Beta
Solution for injection 600 I.U. in 0.72 mL multi‑dose cartridge
Injection
Puregon 600 IU/0.72 mL
MK
 

Follitropin Beta
Solution for injection 900 I.U. in 1.08 mL multi‑dose cartridge
Injection
Puregon 900 IU/1.08 mL
MK
 

Ganirelix
Injection 250 micrograms (as acetate) in 0.5mL pre‑filled syringe
Injection
Orgalutran
MK
D(100)

Human Menopausal Gonadotrophin
Powder for injection 600IU with solvent
Injection
Menopur 600
FP
D(100)

Human Menopausal Gonadotrophin
Powder for injection 1200IU with solvent
Injection
Menopur 1200
FP
D(100)

Nafarelin
Nasal spray (pump pack) 200 micrograms (as acetate) per dose, 60 doses
Nasal
Synarel
PF
 

Progesterone
Vaginal gel (prolonged release) 90 mg in single dose pre‑filled applicator
Vaginal
Crinone 8%
SG
D(100)

Progesterone
Pessary 100 mg
Vaginal
Orion Laboratories Pty Ltd
ON
D(100)

Progesterone
Pessary 200 mg
Vaginal
Orion Laboratories Pty Ltd
ON
D(100)

Schedule 2     Amendments
[1]           Subsection 7(1) 
omit:
letter ‘D’
insert:
code ‘D(100)’
[2]           Subsection 7(3) 
omit:
letters ‘PB’
insert:
code ‘PB(100)’
 
 
 
[3]           Schedule 2, before entry for MK
insert:
FP
Ferring Pharmaceuticals Pty Ltd
87 003 037 170
 
 
 
 
1Note
All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the
Legislative Instruments Act 2003.  See http://www.frli.gov.au.